GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023

Mar 2018 100

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

"Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease"

Scope of the Report:

This report focuses on the Onychomycosis (Tinea Unguium) Drug in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.

Market Segment by Manufacturers, this report covers
- Johnson & Johnson
- GSK
- Novartis
- Pfizer
- Valeant Pharma
- Kaken Pharmaceutical
- Galderma
- Xiuzheng Pharmaceutical
- Letai
- Qilu Pharmaceutical

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Oral
- External

Market Segment by Applications, can be divided into
- Age under 18
- Age 18-50
- Age above 50

There are 15 Chapters to deeply display the global Onychomycosis (Tinea Unguium) Drug market.

Chapter 1, to describe Onychomycosis (Tinea Unguium) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Onychomycosis (Tinea Unguium) Drug , with sales, revenue, and price of Onychomycosis (Tinea Unguium) Drug , in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Onychomycosis (Tinea Unguium) Drug , for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Onychomycosis (Tinea Unguium) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Onychomycosis (Tinea Unguium) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(Apr 18)

Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species m...

(Apr 18)

Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospect...

(Apr 18)

This report studies the Scaffold Material market, Scaffold material is a temporary rigid structure made of still, bamboo or timber. The prim...

(Apr 18)

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group...

(Apr 18)

The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic dru...

(Apr 18)

Vitamin K2 is the term for a group of compounds called ‘menaquinones,’ which can be found mainly in dairy products. All K vitamins are simil...

GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*